Search - tctmd.com

Displaying 641 - 660 of 1743

Sort: Relevancy | Date

Presentation SOLACI 2016

Análise Crítica do Estudo Leaders É o melhor stent que temos?

Presenter: Esmeralci Ferreira

June 09, 2016

News Industry News

STENTYS Announces CE Marking of its longest Xposition stent

June 08, 2016

News Daily News

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Michael O'Riordan

June 06, 2016

News Daily News

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

Michael O'Riordan

June 06, 2016

News Industry News

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

June 06, 2016

News Daily News

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Michael O'Riordan

June 06, 2016

Presentation

Stent Thrombosis With DES and Absorb Bioresorbable Scaffold

Presenter: S.H. Kang

June 03, 2016

News Industry News

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

May 19, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

News Industry News

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

May 19, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Industry News

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

May 17, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Yael L. Maxwell

May 17, 2016

News Daily News

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Michael O'Riordan

April 25, 2016

News Daily News

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Michael O'Riordan

April 25, 2016

Presentation Fellows 2016

Stent Thrombosis and Restenosis

Presenter: William A. Gray, Ajay J. Kirtane

April 16, 2016

Presentation Fellows 2016

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2016

Advertisement

Análise Crítica do Estudo Leaders É o melhor stent que temos?

STENTYS Announces CE Marking of its longest Xposition stent

Según un Meta Análisis en Red el Riesgo de Trombosis del Andamiaje con el BVS Absorb es Mayor que con Otros Stents

Higher Scaffold Thrombosis Risk With Absorb BVS vs a Wide Range of Stents: Network Meta-Analysis

CARDIONOVUM Announces Enrollment Completion of RAPID Trial

Absorb BVS 与多种支架相比支架血栓形成风险更高：网络 Meta 分析

Stent Thrombosis With DES and Absorb Bioresorbable Scaffold

iVascular completes recruitment of patients for its ANCHOR clinical trial of the sirolimus eluting stent ANGIOLITE

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

iVascular Receives CE Mark Approval for LUMINOR 18 Drug Eluting Balloon

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Not Necessarily PERFECT, but Drug-Eluting Balloon Shows Promise for Erectile Dysfunction

Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis

Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes

Stent Thrombosis and Restenosis

Drug-Eluting Stents: Past, Present, and Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content